5RE Stock Overview
Asia Vets Holdings Ltd., through its subsidiary, AVH Animal Ark Pte.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Asia Vets Holdings Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | S$0.026 |
52 Week High | S$0.066 |
52 Week Low | S$0.019 |
Beta | 0.56 |
1 Month Change | -23.53% |
3 Month Change | n/a |
1 Year Change | -60.00% |
3 Year Change | -63.89% |
5 Year Change | -85.87% |
Change since IPO | -88.18% |
Recent News & Updates
Recent updates
Shareholder Returns
5RE | SG Healthcare | SG Market | |
---|---|---|---|
7D | -25.7% | 1.8% | 3.7% |
1Y | -60.0% | -23.3% | -4.1% |
Return vs Industry: 5RE underperformed the SG Healthcare industry which returned -23.3% over the past year.
Return vs Market: 5RE underperformed the SG Market which returned -4.1% over the past year.
Price Volatility
5RE volatility | |
---|---|
5RE Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 6.6% |
Market Average Movement | 5.0% |
10% most volatile stocks in SG Market | 15.8% |
10% least volatile stocks in SG Market | 2.2% |
Stable Share Price: 5RE's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 5RE's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | 21 | Tong Guan Tan | www.asiavets.com |
Asia Vets Holdings Ltd., through its subsidiary, AVH Animal Ark Pte. Ltd., provides veterinary care and clinical services to small animals in Singapore. The company operates two veterinary clinics, which provides general veterinary services including medical, surgical, and dental care for small animals, such as dogs, cats, rabbits, hamsters, guinea pigs, and chinchillas.
Asia Vets Holdings Ltd. Fundamentals Summary
5RE fundamental statistics | |
---|---|
Market cap | S$3.80m |
Earnings (TTM) | -S$744.29k |
Revenue (TTM) | S$2.33m |
1.6x
P/S Ratio-5.1x
P/E RatioIs 5RE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
5RE income statement (TTM) | |
---|---|
Revenue | S$2.33m |
Cost of Revenue | S$1.63m |
Gross Profit | S$698.35k |
Other Expenses | S$1.44m |
Earnings | -S$744.29k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0051 |
Gross Margin | 30.03% |
Net Profit Margin | -32.00% |
Debt/Equity Ratio | 0% |
How did 5RE perform over the long term?
See historical performance and comparison